Related Experiment Video
Updated: Jul 9, 2026

Isolation, Culture, and Functional Characterization of Adult Mouse Cardiomyoctyes
Published on: September 25, 2013
Defects in cardiomyocyte function: role of beta-adrenergic receptor dysfunction.
C Perrino1, G Esposito, H A Rockman
1Department of Medicine, Cell Biology and Molecular Genetics, Duke University Medical Center, Durham, NC, USA.
This review examines the controversial role of beta-adrenergic receptor (betaAR) signaling in heart failure. It explores how betaAR dysfunction impacts failing heart cells and discusses strategies to normalize signaling for improved contractility.
Area of Science:
- Cardiology
- Molecular Biology
- Pharmacology
Background:
- Heart failure is linked to elevated catecholamines and altered beta-adrenergic receptor (betaAR) systems.
- The precise impact of reduced betaAR signaling on failing cardiomyocytes remains debated.
Purpose of the Study:
- To review studies on the role of betaAR dysfunction in heart failure progression.
- To explore novel strategies for normalizing betaAR signaling to enhance cardiomyocyte function.
Main Methods:
- Literature review of studies investigating beta-adrenergic receptor signaling in heart failure.
- Analysis of research on cardiomyocyte contractility and betaAR modulation.
Main Results:
- Beta-adrenergic receptor system is extensively abnormal in heart failure.
- The effect of dampening betaAR signals in failing cardiomyocytes is controversial.
Conclusions:
- Understanding betaAR dysfunction is crucial for heart failure progression.
- Normalizing betaAR signaling presents a potential therapeutic strategy for heart failure.
More Related Videos
Related Concept Videos
Adrenergic Receptors (Adrenoceptors): Classification
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors, which are found on postsynaptic...
Adrenergic Receptors: β Subtype
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Heart Failure Drugs: β-Blockers
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy III: Hypertrophic Cardiomyopathy

